Julia H. Hayes

1.1k total citations
22 papers, 776 citations indexed

About

Julia H. Hayes is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Julia H. Hayes has authored 22 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 6 papers in Oncology. Recurrent topics in Julia H. Hayes's work include Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Julia H. Hayes is often cited by papers focused on Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Julia H. Hayes collaborates with scholars based in United States, Japan and Austria. Julia H. Hayes's co-authors include Michael J. Barry, Philip W. Kantoff, Daniel A. Ollendorf, Pamela M. McMahon, Steven D. Pearson, James E. Stahl, Vibha Bhatnagar, Susan T. Stewart, Christopher J. Sweeney and Paul Flecknell and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

Julia H. Hayes

21 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia H. Hayes United States 11 501 183 155 107 98 22 776
Inger L. Rosner United States 20 730 1.5× 196 1.1× 277 1.8× 124 1.2× 46 0.5× 67 1.1k
Yasin Folkvaljon Sweden 17 595 1.2× 213 1.2× 119 0.8× 247 2.3× 70 0.7× 37 947
Guila Delouya Canada 17 498 1.0× 188 1.0× 98 0.6× 171 1.6× 40 0.4× 102 1.1k
Jan-Erik Johansson Sweden 8 726 1.4× 210 1.1× 107 0.7× 225 2.1× 40 0.4× 9 951
Tuomas P. Kilpeläinen Finland 13 358 0.7× 172 0.9× 61 0.4× 96 0.9× 47 0.5× 35 495
Tatsuo Tochigi Japan 21 708 1.4× 175 1.0× 175 1.1× 188 1.8× 29 0.3× 61 999
Anna Ceribelli Italy 15 449 0.9× 577 3.2× 159 1.0× 112 1.0× 66 0.7× 35 1.0k
Jun Kawakami Canada 14 452 0.9× 123 0.7× 209 1.3× 162 1.5× 36 0.4× 40 653
Edward P. DeAntoni United States 15 442 0.9× 121 0.7× 60 0.4× 97 0.9× 42 0.4× 23 643
Mohamed Jalloh Senegal 15 429 0.9× 185 1.0× 106 0.7× 198 1.9× 24 0.2× 85 778

Countries citing papers authored by Julia H. Hayes

Since Specialization
Citations

This map shows the geographic impact of Julia H. Hayes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia H. Hayes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia H. Hayes more than expected).

Fields of papers citing papers by Julia H. Hayes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia H. Hayes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia H. Hayes. The network helps show where Julia H. Hayes may publish in the future.

Co-authorship network of co-authors of Julia H. Hayes

This figure shows the co-authorship network connecting the top 25 collaborators of Julia H. Hayes. A scholar is included among the top collaborators of Julia H. Hayes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia H. Hayes. Julia H. Hayes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berry, Donna L., Fangxin Hong, Traci M. Blonquist, et al.. (2021). Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial. Urologic Oncology Seminars and Original Investigations. 39(8). 493.e9–493.e15. 14 indexed citations
2.
Berry, Donna L., Fangxin Hong, Traci M. Blonquist, et al.. (2017). Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial. The Journal of Urology. 199(1). 89–97. 34 indexed citations
3.
McKay, Rana R., Kathryn P. Gray, Julia H. Hayes, et al.. (2015). Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer. Cancer. 121(15). 2603–2611. 7 indexed citations
4.
Barry, Michael J. & Julia H. Hayes. (2015). Evaluating an Elevated Screening PSA Test. JAMA. 314(19). 2073–2073. 5 indexed citations
5.
McKay, Rana R., Kathryn P. Gray, Julia H. Hayes, et al.. (2014). Results of a phase II trial of docetaxel (DOC), bevacizumab (BEV), and androgen deprivation therapy (ADT) for biochemical relapse (BCR) after definitive local therapy for prostate cancer (PC).. Journal of Clinical Oncology. 32(4_suppl). 54–54. 1 indexed citations
6.
Hayes, Julia H., Daniel A. Ollendorf, Steven D. Pearson, et al.. (2013). Observation Versus Initial Treatment for Men With Localized, Low-Risk Prostate Cancer. Annals of Internal Medicine. 158(12). 853–860. 86 indexed citations
7.
Berry, Donna L., et al.. (2013). Health literacy screening prior to education for patients with cancer.. Journal of Clinical Oncology. 31(31_suppl). 155–155. 1 indexed citations
8.
Nakabayashi, Mari, Kevin D. Courtney, Geoffrey Buckle, et al.. (2012). Phase II trial of RAD001 and bicalutamide for castration‐resistant prostate cancer. British Journal of Urology. 110(11). 1729–1735. 62 indexed citations
9.
Sneag, Darryl B., Nikhil H. Ramaiya, Kevin N. O’Regan, et al.. (2011). Peritoneal Relapse of Testicular Seminomatous Germ Cell Tumor Treated Successfully With Salvage Chemotherapy and Autologous Stem Cell Transplantation. Clinical Genitourinary Cancer. 9(2). 124–129. 1 indexed citations
10.
Hayes, Julia H., Ming‐Hui Chen, Brian J. Moran, et al.. (2010). Androgen‐suppression therapy for prostate cancer and the risk of death in men with a history of myocardial infarction or stroke. British Journal of Urology. 106(7). 979–985. 19 indexed citations
11.
Choueiri, Toni K., Ming‐Hui Chen, Anthony V. D’Amico, et al.. (2010). Impact of postoperative prostate‐specific antigen disease recurrence and the use of salvage therapy on the risk of death. Cancer. 116(8). 1887–1892. 25 indexed citations
12.
Hayes, Julia H., Daniel A. Ollendorf, Steven D. Pearson, et al.. (2010). Active Surveillance Compared With Initial Treatment for Men With Low-Risk Prostate Cancer. JAMA. 304(21). 2373–2373. 194 indexed citations
13.
Hayes, Julia H., et al.. (2010). Therapeutic options for low-risk prostate cancer: A cost-effectiveness analysis.. Journal of Clinical Oncology. 28(15_suppl). 6012–6012. 1 indexed citations
14.
Oh, William, Philip G. Febbo, John P. Richie, et al.. (2009). A phase II study of neoadjuvant chemotherapy with docetaxel and bevacizumab in patients (pts) with high-risk localized prostate cancer: A Prostate Cancer Clinical Trials Consortium trial. Journal of Clinical Oncology. 27(15_suppl). 5060–5060. 3 indexed citations
15.
Hayes, Julia H., Brian J. Moran, Michelle H. Braccioforte, et al.. (2009). Short-course androgen suppression therapy prior to brachytherapy for favorable-risk prostate cancer and the risk of all-cause mortality in men with or without preexisting cardiovascular disease. Journal of Clinical Oncology. 27(15_suppl). 5066–5066.
16.
Hayes, Julia H., Michael J. Barry, Philip W. Kantoff, & James E. Stahl. (2007). PROSTATE‐SPECIFIC ANTIGEN SCREENING FOR PROSTATE CANCER: A DECISION‐ANALYTICAL PERSPECTIVE. British Journal of Urology. 100(3). 486–488. 2 indexed citations
17.
Hayes, Julia H., William Oh, Philip W. Kantoff, et al.. (2006). Mifepristone (RU-486) in androgen independent prostate cancer. Journal of Clinical Oncology. 24(18_suppl). 14508–14508. 1 indexed citations
18.
Shimizu, Masahito, Masumi Suzui, Atsuko Deguchi, et al.. (2004). Synergistic Effects of Acyclic Retinoid and OSI-461 on Growth Inhibition and Gene Expression in Human Hepatoma Cells. Clinical Cancer Research. 10(19). 6710–6721. 25 indexed citations
19.
Hayes, Julia H., et al.. (1999). Hepatic Sequestration and Modulation of the Canalicular Transport of the Organic Cation, Daunorubicin, in the Rat. Hepatology. 29(2). 483–493. 15 indexed citations
20.
Hayes, Julia H. & Paul Flecknell. (1999). A comparison of pre- and post-surgical administration of bupivacaine or buprenorphine following laparotomy in the rat. Laboratory Animals. 33(1). 16–23. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Inger L. Rosner Breakdown of academic impact, for papers by Yasin Folkvaljon Breakdown of academic impact, for papers by Guila Delouya Breakdown of academic impact, for papers by Jan-Erik Johansson Breakdown of academic impact, for papers by Tuomas P. Kilpeläinen Breakdown of academic impact, for papers by Tatsuo Tochigi Breakdown of academic impact, for papers by Anna Ceribelli Breakdown of academic impact, for papers by Jun Kawakami Breakdown of academic impact, for papers by Edward P. DeAntoni Breakdown of academic impact, for papers by Mohamed Jalloh
Rankless by CCL
2026